Targeting cytotoxic T lymphocytes for cancer immunotherapy

In light of their preeminent role in cellular immunity, there is considerable interest in targeting of cytotoxic T-lymphocytes to cancer. This review summarises the active and passive immunotherapeutic approaches under development to achieve this goal, emphasising how recent advances in tumour immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Maher, J, Davies, E T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409863/
https://www.ncbi.nlm.nih.gov/pubmed/15266309
http://dx.doi.org/10.1038/sj.bjc.6602022
_version_ 1782155884117360640
author Maher, J
Davies, E T
author_facet Maher, J
Davies, E T
author_sort Maher, J
collection PubMed
description In light of their preeminent role in cellular immunity, there is considerable interest in targeting of cytotoxic T-lymphocytes to cancer. This review summarises the active and passive immunotherapeutic approaches under development to achieve this goal, emphasising how recent advances in tumour immunology and gene transfer have impacted upon this field.
format Text
id pubmed-2409863
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24098632009-09-10 Targeting cytotoxic T lymphocytes for cancer immunotherapy Maher, J Davies, E T Br J Cancer Minireview In light of their preeminent role in cellular immunity, there is considerable interest in targeting of cytotoxic T-lymphocytes to cancer. This review summarises the active and passive immunotherapeutic approaches under development to achieve this goal, emphasising how recent advances in tumour immunology and gene transfer have impacted upon this field. Nature Publishing Group 2004-08-31 2004-07-13 /pmc/articles/PMC2409863/ /pubmed/15266309 http://dx.doi.org/10.1038/sj.bjc.6602022 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Minireview
Maher, J
Davies, E T
Targeting cytotoxic T lymphocytes for cancer immunotherapy
title Targeting cytotoxic T lymphocytes for cancer immunotherapy
title_full Targeting cytotoxic T lymphocytes for cancer immunotherapy
title_fullStr Targeting cytotoxic T lymphocytes for cancer immunotherapy
title_full_unstemmed Targeting cytotoxic T lymphocytes for cancer immunotherapy
title_short Targeting cytotoxic T lymphocytes for cancer immunotherapy
title_sort targeting cytotoxic t lymphocytes for cancer immunotherapy
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409863/
https://www.ncbi.nlm.nih.gov/pubmed/15266309
http://dx.doi.org/10.1038/sj.bjc.6602022
work_keys_str_mv AT maherj targetingcytotoxictlymphocytesforcancerimmunotherapy
AT davieset targetingcytotoxictlymphocytesforcancerimmunotherapy

Ejemplares similares